# Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

> **NCT00683514** · PHASE3 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 201 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Oral Vinorelbine and cisplatin with concomitant radiotherapy 66 Gy (total dose)
- **DRUG:** Oral Vinorelbine and cisplatin with concomitant radiotherapy 66 Gy (total dose)

## Key facts

- **NCT ID:** NCT00683514
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2016-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683514, "Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00683514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*